Potential threats of cholera amidst COVID pandemic in the Democratic Republic of Congo; bridging the gaps: a review
Aymar Akilimali(Roslin Institute), Paterne Bisimwa(Université Catholique de Bukavu), Kennedy Basima(Green Circle), Bonk Muhoza(Université Officielle de Bukavu), Hugues Cakwira(Green Circle), Styves Banga(Green Circle), Chrispin Biamba(University of Goma), Michel K. Mirindi, Innocent Mufungizi(Green Circle), Guillain Ramandizi(Université Officielle de Bukavu), Alain Balume(Université Officielle de Bukavu), Malik Olatunde Oduoye(Ahmadu Bello University), Gentil Rajabu(Faculty (United Kingdom)), Gaston Masimango(Green Circle), Adolphe Aganze(Université Officielle de Bukavu), Louison Kena(Université libre des Pays des Grands Lacs)
Cited by 5
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29